These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. [Treatment for recurrence of uterine cervical neoplasms]. Sakamoto N; Fukasawa I; Inaba N Gan To Kagaku Ryoho; 2009 Feb; 36(2):209-14. PubMed ID: 19263608 [No Abstract] [Full Text] [Related]
47. Treatment of high-risk cervical cancer. Piver MS N Engl J Med; 1999 Aug; 341(9):696-7. PubMed ID: 10475823 [No Abstract] [Full Text] [Related]
48. [Concurrent weekly nedaplatin-based radiotherapy for high risk, recurrent and advanced cervical cancer]. Idei T; Sakamoto H; Nakajima Y; Hiraiwa Y; Takami N; Chishima F; Ohtani K; Nagaishi M; Yamamoto T; Kawamori J; Himi K; Tanaka Y Gan To Kagaku Ryoho; 2003 Apr; 30(4):505-9. PubMed ID: 12722682 [TBL] [Abstract][Full Text] [Related]
49. Postoperative adjuvant concurrent chemoradiotherapy improves survival rates for high-risk, early stage cervical cancer patients. Ryu HS; Chun M; Chang KH; Chang HJ; Lee JP Gynecol Oncol; 2005 Feb; 96(2):490-5. PubMed ID: 15661240 [TBL] [Abstract][Full Text] [Related]
50. Does adjuvant chemotherapy change the prognosis of cervical cancer? Morton GC; Thomas GM Curr Opin Obstet Gynecol; 1996 Feb; 8(1):17-20. PubMed ID: 8777252 [TBL] [Abstract][Full Text] [Related]
51. Radiation injury to intestine following hysterectomy and adjuvant radiotherapy for cervical cancer. Chen SW; Liang JA; Yang SN; Hung YC; Yeh LS; Shiau AC; Lin FJ Gynecol Oncol; 2004 Oct; 95(1):208-14. PubMed ID: 15385134 [TBL] [Abstract][Full Text] [Related]
52. Clinical outcome in posthysterectomy cervical cancer patients treated with concurrent Cisplatin and intensity-modulated pelvic radiotherapy: comparison with conventional radiotherapy. Chen MF; Tseng CJ; Tseng CC; Kuo YC; Yu CY; Chen WC Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1438-44. PubMed ID: 17394944 [TBL] [Abstract][Full Text] [Related]
53. [Cancer of the uterine cervix: combination of radiotherapy and cisplatin chemotherapy (chemoradiotherapy) is superior to radiotherapy alone in local advanced stages]. Mazeron JJ Bull Cancer; 1999 Mar; 86(3):247-8. PubMed ID: 10847719 [No Abstract] [Full Text] [Related]
54. Operative management of cervical cancer. Dreyer G Best Pract Res Clin Obstet Gynaecol; 2005 Aug; 19(4):563-76. PubMed ID: 16150394 [TBL] [Abstract][Full Text] [Related]
55. Secondary Prevention, Not Secondary Importance: Embracing Survivorship Concerns and HRT After Cervical Cancer Radiation Therapy. Damast S; Chino J Int J Radiat Oncol Biol Phys; 2022 Feb; 112(2):414-416. PubMed ID: 34998535 [No Abstract] [Full Text] [Related]
56. Biochemical effects of alkoxyglycerols and their use in cancer therapy. Brohult A; Brohult J; Brohult S Acta Chem Scand; 1970; 24(2):730. PubMed ID: 5426221 [No Abstract] [Full Text] [Related]
57. Oestrogen increases S-phase fraction and oestrogen and progesterone receptors in human cervical cancer in vivo. Bhattacharya D; Redkar A; Mittra I; Sutaria U; MacRae KD Br J Cancer; 1997; 75(4):554-8. PubMed ID: 9052410 [TBL] [Abstract][Full Text] [Related]
58. Nuclear and cytoplasmic oestrogen receptors in squamous carcinoma of the cervix. Soutter WP; Pegoraro RJ; Green-Thompson RW; Naidoo DV; Joubert SM; Philpott RH Br J Cancer; 1981 Aug; 44(2):154-9. PubMed ID: 7272184 [TBL] [Abstract][Full Text] [Related]
59. Adjuvant hormone therapy to radiation treatment for cervical cancer. Sugimori H; Taki I; Koga K Acta Obstet Gynaecol Jpn; 1976 Apr; 23(2):77-82. PubMed ID: 1026040 [No Abstract] [Full Text] [Related]
60. [The additional hormone and cytostatic therapy of the vterine cervix carcinoma. Based on a report from the meeting of the Northwest German Society of Gynecology in Bad Pyrmont on October 27-29, 1967]. Wimhöfer H Geburtshilfe Frauenheilkd; 1968 Jul; 28(7):609-16. PubMed ID: 5681958 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]